Biologics / mAb CDMOs with Clean FDA Inspection History
Biologics CDMOs manufacture monoclonal antibodies, fusion proteins, and other large molecules in mammalian (typically CHO) cell culture. It is the largest and most mature segment of contract manufacturing, spanning early clinical supply through multi-thousand-litre commercial production.
Selecting a biologics CDMO turns on bioreactor scale and modality fit (mAb, bispecific, fusion protein), titer and cell-line strategy, fill-finish, and — above all — a clean regulatory record at commercial scale. The rankings below score each CDMO on FDA inspection history, EMA/MHRA GMP certification, clinical-program activity, and capacity.
FDA inspection outcomes across these CDMOs: 24 NAI (no action), 29 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (35), Denmark (29), UNITED KINGDOM (29), Germany (21), Italy (16).
Last updated 2026-11-20. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Ranked by Signal Score (0–100). Fully evidenced marks a CDMO scored on all four pillars with at least one confirmed clinical program. Partly scored and profile-only CDMOs follow the scored rows. How we score
Showing all operator types.
| # | CDMO | Signal Score | Quality | FDA · GMP | Last FDA inspection | Capacity | Programs |
|---|---|---|---|---|---|---|---|
| 1 |
PC
|
90.1 | 100.0 | 4 insp · 14 GMP | 2025-12-16 · NAI | — | 366 programs |
| 2 |
PR
Lexington, KY · Riverview, MI · Ahmedabad, IN
|
86.9 | 96.0 | 7 insp · 15 GMP | 2026-02-13 · VAI | — | — |
| 3 |
FD
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Hiring · 20 open roles
|
86.7 | 100.0 | 0 insp · 35 GMP | None on file | — | |
| 4 |
AJ
San Diego, CA · Osaka, JP
|
83.5 | 100.0 | 0 insp · 1 GMP | None on file | — | — |
| 5 |
CD
Plankstadt, DE · Caponago, IT · Boulder, CO
|
83.1 | 99.3 | 5 insp · 17 GMP | 2025-11-14 · NAI | — | — |
| 6 |
RB
Hamburg, Germany
|
82.9 | 100.0 | 0 insp · 9 GMP | None on file | — | — |
| 7 |
MK
Darmstadt, DE · St. Louis, MO
Hiring · 8 open roles
Fully evidenced
Also makes its own products
|
81.9 | 98.8 | 2 insp · 2 GMP | 2025-04-28 · VAI | — | 22 programs |
| 8 |
LB
|
81.6 | 100.0 | 2 insp · 0 GMP | 2026-09-18 · NAI | — | — |
| 9 |
EF
Planegg, DE · San Diego, CA
|
81.6 | 100.0 | 7 insp · 0 GMP | 2026-05-15 · NAI | — | — |
| 10 |
EK
Birmingham, AL · Vancouver, BC
|
81.5 | 99.8 | 2 insp · 2 GMP | 2025-09-11 · NAI | — | — |
| 11 |
NW
|
80.8 | 100.0 | 0 insp · 8 GMP | None on file | Available | — |
| 12 |
SG
|
80.3 | 100.0 | 3 insp · 0 GMP | 2025-02-20 · NAI | — | — |
| 13 |
BR
|
80.3 | 97.2 | 6 insp · 10 GMP | 2026-05-13 · VAI | — | — |
| 14 |
CRA
|
79.5 | 100.0 | 2 insp · 18 GMP | 2025-12-02 · NAI | — | — |
| 15 |
AV
|
78.9 | 100.0 | 1 insp · 0 GMP | 2025-05-29 · NAI | — | — |
| 16 |
Oklahoma City, OK
|
78.6 | 98.2 | 1 insp · 0 GMP | 2026-06-17 · VAI | Available | — |
| 17 |
PG
Berlin, DE
|
78.1 | 100.0 | 0 insp · 4 GMP | None on file | — | — |
| 18 |
BT
Charlottetown, PE, Canada
|
76.5 | 99.4 | 1 insp · 0 GMP | 2022-08-26 · VAI | — | — |
| 19 |
KD
Woodbury, MN
|
76.1 | 98.5 | 3 insp · 9 GMP | 2025-11-13 · VAI | — | — |
| 20 |
AF
|
75.2 | 96.5 | 3 insp · 1 GMP | 2024-05-08 · VAI | — | — |
| 21 |
GM
|
74.4 | 92.1 | 4 insp · 0 GMP | 2025-11-04 · VAI | — | — |
| 22 |
SI
|
74.3 | 91.8 | 0 insp · 1 GMP | None on file Warning letter 2026-03-03 |
— | — |